NeoChord System for Mitral Valve Disease
Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- NeoChord · Industry
This trial is looking for people with certain types of mitral valve problems who have undergone a specific procedure since December 2016. Participants will be followed for five years to see how well the treatment works.
You may be able to join if
- I have Grade III Moderate or Grade IV Severe mitral valve regurgitation
- I completed the study procedure after December 31, 2016
You may not be able to join if
- I have heavily calcified heart valves
- I have severe valve retraction that limits movement
- I have active bacterial endocarditis
- I have a complex mechanism of mitral regurgitation
- I have significant tethering of the valve leaflets
- I have inflammatory valve disease
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe objective of this study is to evaluate the 5-year outcomes of participants with degenerative mitral valve disease treated with the NeoChord Artificial Chordae System, Model DS1000 in a post-market setting.
Loading trial locations…